Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.

<h4>Background</h4>Qualitative evidence suggests patient-reported outcome (PRO) information is frequently absent from clinical trial protocols, potentially leading to inconsistent PRO data collection and risking bias. Direct evidence regarding PRO trial protocol content is lacking. The a...

Full description

Saved in:
Bibliographic Details
Main Authors: Derek Kyte, Helen Duffy, Benjamin Fletcher, Adrian Gheorghe, Rebecca Mercieca-Bebber, Madeleine King, Heather Draper, Jonathan Ives, Michael Brundage, Jane Blazeby, Melanie Calvert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0110229
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726725109317632
author Derek Kyte
Helen Duffy
Benjamin Fletcher
Adrian Gheorghe
Rebecca Mercieca-Bebber
Madeleine King
Heather Draper
Jonathan Ives
Michael Brundage
Jane Blazeby
Melanie Calvert
author_facet Derek Kyte
Helen Duffy
Benjamin Fletcher
Adrian Gheorghe
Rebecca Mercieca-Bebber
Madeleine King
Heather Draper
Jonathan Ives
Michael Brundage
Jane Blazeby
Melanie Calvert
author_sort Derek Kyte
collection DOAJ
description <h4>Background</h4>Qualitative evidence suggests patient-reported outcome (PRO) information is frequently absent from clinical trial protocols, potentially leading to inconsistent PRO data collection and risking bias. Direct evidence regarding PRO trial protocol content is lacking. The aim of this study was to systematically evaluate the PRO-specific content of UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme trial protocols.<h4>Methods and findings</h4>We conducted an electronic search of the NIHR HTA programme database (inception to August 2013) for protocols describing a randomised controlled trial including a primary/secondary PRO. Two investigators independently reviewed the content of each protocol, using a specially constructed PRO-specific protocol checklist, alongside the 'Standard Protocol Items: Recommendations for Interventional Trials' (SPIRIT) checklist. Disagreements were resolved through discussion with a third investigator. 75 trial protocols were included in the analysis. Protocols included a mean of 32/51 (63%) SPIRIT recommendations (range 16-41, SD 5.62) and 11/33 (33%) PRO-specific items (range 4-18, SD 3.56). Over half (61%) of the PRO items were incomplete. Protocols containing a primary PRO included slightly more PRO checklist items (mean 14/33 (43%)). PRO protocol content was not associated with general protocol completeness; thus, protocols judged as relatively 'complete' using SPIRIT were still likely to have omitted a large proportion of PRO checklist items.<h4>Conclusions</h4>The PRO components of HTA clinical trial protocols require improvement. Information on the PRO rationale/hypothesis, data collection methods, training and management was often absent. This low compliance is unsurprising; evidence shows existing PRO guidance for protocol developers remains difficult to access and lacks consistency. Study findings suggest there are a number of PRO protocol checklist items that are not fully addressed by the current SPIRIT statement. We therefore advocate the development of consensus-based supplementary guidelines, aimed at improving the completeness and quality of PRO content in clinical trial protocols.
format Article
id doaj-art-ef4edc915dde45a78f4e0443fe006a90
institution DOAJ
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-ef4edc915dde45a78f4e0443fe006a902025-08-20T03:10:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e11022910.1371/journal.pone.0110229Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.Derek KyteHelen DuffyBenjamin FletcherAdrian GheorgheRebecca Mercieca-BebberMadeleine KingHeather DraperJonathan IvesMichael BrundageJane BlazebyMelanie Calvert<h4>Background</h4>Qualitative evidence suggests patient-reported outcome (PRO) information is frequently absent from clinical trial protocols, potentially leading to inconsistent PRO data collection and risking bias. Direct evidence regarding PRO trial protocol content is lacking. The aim of this study was to systematically evaluate the PRO-specific content of UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme trial protocols.<h4>Methods and findings</h4>We conducted an electronic search of the NIHR HTA programme database (inception to August 2013) for protocols describing a randomised controlled trial including a primary/secondary PRO. Two investigators independently reviewed the content of each protocol, using a specially constructed PRO-specific protocol checklist, alongside the 'Standard Protocol Items: Recommendations for Interventional Trials' (SPIRIT) checklist. Disagreements were resolved through discussion with a third investigator. 75 trial protocols were included in the analysis. Protocols included a mean of 32/51 (63%) SPIRIT recommendations (range 16-41, SD 5.62) and 11/33 (33%) PRO-specific items (range 4-18, SD 3.56). Over half (61%) of the PRO items were incomplete. Protocols containing a primary PRO included slightly more PRO checklist items (mean 14/33 (43%)). PRO protocol content was not associated with general protocol completeness; thus, protocols judged as relatively 'complete' using SPIRIT were still likely to have omitted a large proportion of PRO checklist items.<h4>Conclusions</h4>The PRO components of HTA clinical trial protocols require improvement. Information on the PRO rationale/hypothesis, data collection methods, training and management was often absent. This low compliance is unsurprising; evidence shows existing PRO guidance for protocol developers remains difficult to access and lacks consistency. Study findings suggest there are a number of PRO protocol checklist items that are not fully addressed by the current SPIRIT statement. We therefore advocate the development of consensus-based supplementary guidelines, aimed at improving the completeness and quality of PRO content in clinical trial protocols.https://doi.org/10.1371/journal.pone.0110229
spellingShingle Derek Kyte
Helen Duffy
Benjamin Fletcher
Adrian Gheorghe
Rebecca Mercieca-Bebber
Madeleine King
Heather Draper
Jonathan Ives
Michael Brundage
Jane Blazeby
Melanie Calvert
Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
PLoS ONE
title Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
title_full Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
title_fullStr Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
title_full_unstemmed Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
title_short Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
title_sort systematic evaluation of the patient reported outcome pro content of clinical trial protocols
url https://doi.org/10.1371/journal.pone.0110229
work_keys_str_mv AT derekkyte systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT helenduffy systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT benjaminfletcher systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT adriangheorghe systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT rebeccamerciecabebber systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT madeleineking systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT heatherdraper systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT jonathanives systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT michaelbrundage systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT janeblazeby systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols
AT melaniecalvert systematicevaluationofthepatientreportedoutcomeprocontentofclinicaltrialprotocols